Bintai appoints cold chain box distributor for Covid vaccine


BINTAI Kinden Corp Bhd’s unit, Bintai Healthcare Sdn Bhd, will be the exclusive distributor for Greenie Medi Cold Chain Box for the storage and distribution of its Covid-19 vaccine in Malaysia.

Bintai Healthcare was also appointed as an authorised distributor for the product in South-East Asian countries, namely Brunei, Myanmar, Cambodia, Timor-Leste, Indonesia, Laos, the Philippines, Singapore, Thailand and Vietnam.

Bintai Kinden MD Ong Choon Lui said the group supports the government’s initiatives in vaccine distribution in the country, while complementing the existing cold chain infrastructure and providing comprehensive solutions to meet critical needs amid the pandemic.

“Greenie Medi Cold Chain Box is the ideal solution for getting temperature sensitive drugs, biologics and vaccines safely to end users across Malaysia and beyond,” he said in a statement last Friday.

The storage box was designed for the exclusive use in transporting and storing medical products at very low temperatures as it keeps the inbox temperature at -70°C for up to 120 hours.

SLAB Asia Co Ltd is among the leading cold chain equipment manufacturers in South Korea and operates Korea’s only ISTA 7D/7E certificate private test lab, which offers its customers an internationally recognised quality assurance.

ISTA 7D/7E is a test standard set by the Centre for Drug Evaluation and Research parked under the US Food and Drug Administration in certifying compatibility and adequacy for transporting medical grade products.

The deal is expected to contribute positively towards the group’s future earnings.

In October last year, Bintai Kinden ventured into the distribution of Covid-19 vaccine with Bintai Healthcare, following exclusive rights received from Generex Biotechnology Corp and its subsidiary NuGenerex Immuno-Oncology Inc to distribute, sell and commercialise their vaccine in Malaysia and other countries in the region.

It was also given the first right of refusal to distribute and market the vaccine within Australia, New Zealand and the global halal market.